Inventor · disambiguated record
Catherine A. Evans
Also filed as: EVANS CATHERINE A · EVANS CATHERINE ANNE
44 granted patents·13 pending applications·482 citations·filing 2004–2024
98Inventor score
Files withINFINITY PHARMACEUTICALS INC34BEHNKE MARK L4CASTRO ALFREDO C4IKENA ONCOLOGY INC4KYN THERAPEUTICS3
Top patents by PatentIndex Score
57 records- 0197US9181221B2Chemical compounds, compositions and methods for kinase modulationINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Nov 10, 2015·64 cites·18 claims
- 0297US8785470B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Jul 22, 2014·41 cites·24 claims
- 0397US8604032B2Chemical compounds, compositions and methods for kinase modulationREN PINGDA·Filed 2011·Granted Dec 10, 2013·48 cites·42 claims
- 0496US9359365B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jun 7, 2016·24 cites·24 claims
- 0596US8969363B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Mar 3, 2015·44 cites·56 claims
- 0696US8940742B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Jan 27, 2015·35 cites·48 claims
- 0796US8901133B2Heterocyclic compounds and uses thereofREN PINGDA·Filed 2011·Granted Dec 2, 2014·44 cites·54 claims
- 0895US11358969B2Indole AHR inhibitors and uses thereofIKENA ONCOLOGY INC·Filed 2020·Granted Jun 14, 2022·3 cites·20 claims
- 0995US9115141B2Substituted isoquinolinones and methods of treatment thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 25, 2015·27 cites·49 claims
- 1094US10689388B1Indole AHR inhibitors and uses thereofKYN THERAPEUTICS·Filed 2019·Granted Jun 23, 2020·6 cites·20 claims
- 1194US9775844B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Oct 3, 2017·13 cites·48 claims
- 1294US9255108B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·21 cites·45 claims
- 1393US9708348B2Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Jul 18, 2017·13 cites·21 claims
- 1493US9056877B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Jun 16, 2015·25 cites·32 claims
- 1592US10329299B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·7 cites·26 claims
- 1692US9388183B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jul 12, 2016·19 cites·26 claims
- 1791US11541059B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Jan 3, 2023·2 cites·11 claims
- 1891US10570138B2Indole AHR inhibitors and uses thereofKYN THERAPEUTICS·Filed 2018·Granted Feb 25, 2020·8 cites·17 claims
- 1988US12071438B2Crystal forms of an ALK2 inhibitorKEROS THERAPEUTICS INC·Filed 2021·Granted Aug 27, 2024·2 cites·17 claims
- 2088US10696650B2AHR inhibitors and uses thereofKYN THERAPEUTICS·Filed 2018·Granted Jun 30, 2020·3 cites·20 claims
- 2187US9828377B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·4 cites·43 claims
- 2287US7947663B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2007·Granted May 24, 2011·6 cites·12 claims
- 2387US2025122205A1Indole ahr inhibitors and uses thereofIKENA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 2486US10759806B2Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Sep 1, 2020·3 cites·22 claims
- 2582US8349814B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2011·Granted Jan 8, 2013·3 cites·17 claims
- 2682US2025171453A1Heterocyclic compounds and uses thereofTWELVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2781US9605003B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Mar 28, 2017·3 cites·39 claims
- 2881US8629125B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2012·Granted Jan 14, 2014·3 cites·18 claims
- 2980US12077542B2Indole AHR inhibitors and uses thereofIKENA ONCOLOGY INC·Filed 2022·Granted Sep 3, 2024·0 cites·20 claims
- 3079US9751888B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Sep 5, 2017·2 cites·19 claims
- 3178US8541581B2Inhibitors of fatty acid amide hydrolaseCASTRO ALFREDO C·Filed 2010·Granted Sep 24, 2013·3 cites·25 claims
- 3278US2024050437A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3377US9546180B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jan 17, 2017·2 cites·29 claims
- 3477US8329675B2Inhibitors of fatty acid amide hydrolaseADAMS JULIAN·Filed 2011·Granted Dec 11, 2012·2 cites·31 claims
- 3576US12152032B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2021·Granted Nov 26, 2024·0 cites·17 claims
- 3675US9108989B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·1 cites·16 claims
- 3768US8765735B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Jul 1, 2014·1 cites·30 claims
- 3868US2019367521A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3967US10941162B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·0 cites·15 claims
- 4060US11555026B2AHR inhibitors and uses thereofIKENA ONCOLOGY INC·Filed 2020·Granted Jan 17, 2023·0 cites·23 claims
- 4159US2024368122A1Jak2 inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4257US2024190855A1Cdk inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4357US2015344503A1Inhibitors of fatty acid amide hydrolase, methods of treatment and methods of preparing sameINFINITY PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4456US2017137407A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4555US10253047B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Apr 9, 2019·0 cites·12 claims
- 4653US8802119B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 12, 2014·0 cites·53 claims
- 4753US2015099738A1Isoxazolines as inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4851US9738644B2Chemical compounds, compositions and methods for kinase modulationINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·0 cites·30 claims
- 4949US2016244452A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 5049US2016207940A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Catherine A. Evans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →